These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34663928)

  • 41. A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol.
    van Rhijn-Brouwer FCC; Gremmels H; Fledderus JO; Schuurman AH; Bonte-Mineur F; Vonk MC; Voskuyl AE; de Vries-Bouwstra JK; Coert JH; Radstake TRDJ; van Laar JM; Verhaar MC;
    BMJ Open; 2018 Aug; 8(8):e020479. PubMed ID: 30127049
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human mesenchymal stem cells for the management of systemic sclerosis. Systematic review.
    Escobar-Soto CH; Mejia-Romero R; Aguilera N; Alzate-Granados JP; Mendoza-Pinto C; Munguía-Realpozo P; Méndez-Martínez S; García-Carrasco M; Rojas-Villarraga A
    Autoimmun Rev; 2021 Jun; 20(6):102831. PubMed ID: 33878487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.
    Khanna D; Caldron P; Martin RW; Kafaja S; Spiera R; Shahouri S; Shah A; Hsu V; Ervin J; Simms R; Domsic RT; Steen V; Hummers LK; Derk C; Mayes M; Chatterjee S; Varga J; Kesten S; Fraser JK; Furst DE
    Arthritis Rheumatol; 2022 Aug; 74(8):1399-1408. PubMed ID: 35358372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Update on mesenchymal stem cell-based therapy in lupus and scleroderma.
    Cras A; Farge D; Carmoi T; Lataillade JJ; Wang DD; Sun L
    Arthritis Res Ther; 2015 Nov; 17():301. PubMed ID: 26525582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis.
    Scuderi N; Ceccarelli S; Onesti MG; Fioramonti P; Guidi C; Romano F; Frati L; Angeloni A; Marchese C
    Cell Transplant; 2013; 22(5):779-95. PubMed ID: 22526170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adult stem cell treatment of scleroderma.
    Tyndall A; Furst DE
    Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional implantation of autologous adipose tissue-derived cells induces a prompt healing of long-lasting indolent digital ulcers in patients with systemic sclerosis.
    Del Papa N; Di Luca G; Sambataro D; Zaccara E; Maglione W; Gabrielli A; Fraticelli P; Moroncini G; Beretta L; Santaniello A; Sambataro G; Ferraresi R; Vitali C
    Cell Transplant; 2015; 24(11):2297-305. PubMed ID: 25506730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adipose Tissue and Adipose-Tissue-Derived Cell Therapies for the Treatment of the Face and Hands of Patients Suffering from Systemic Sclerosis.
    Coulange Zavarro A; Velier M; Arcani R; Abellan Lopez M; Simoncini S; Benyamine A; Gomes De Pinho Q; Coatmeur R; Wang J; Xia J; Barone L; Casanova D; Dignat-George F; Sabatier F; Granel B; Magalon J; Daumas A
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-Classical HLA Determinants of the Clinical Response after Autologous Stem Cell Transplantation for Systemic Sclerosis.
    Boukouaci W; Lansiaux P; Lambert NC; Picard C; Clave E; Cras A; Marjanovic Z; Farge D; Tamouza R
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adipose tissue and adipose secretome in systemic sclerosis.
    Brezovec N; Burja B; Lakota K
    Curr Opin Rheumatol; 2021 Nov; 33(6):505-513. PubMed ID: 34534166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives.
    Di Benedetto P; Ruscitti P; Cipriani P; Giacomelli R
    Autoimmun Rev; 2020 Nov; 19(11):102662. PubMed ID: 32942028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis.
    Ramalingam S; Shah A
    Curr Allergy Asthma Rep; 2021 Mar; 21(3):22. PubMed ID: 33759038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Infectious complications of systemic sclerosis].
    Bussone G; Berezné A; Mouthon L
    Presse Med; 2009 Feb; 38(2):291-302. PubMed ID: 19062246
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Fat Grafting Containing Stem Cells in Microstomia and Microcheilia Derived from Systemic Sclerosis.
    Blezien O; D'Andrea F; Nicoletti GF; Ferraro GA
    Aesthetic Plast Surg; 2017 Aug; 41(4):839-844. PubMed ID: 28597066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autologous hematopoietic stem cell transplantation reverses skin fibrosis but does not change skin vessel density in patients with systemic sclerosis.
    Daikeler T; Kump E; Stern M; Hügle T; Hij A; Haeuserman P; Farge D
    Pathol Biol (Paris); 2015 Sep; 63(4-5):164-8. PubMed ID: 26300240
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relevance of immunomodulatory therapy for interstitial lung disease in systemic sclerosis.
    Aringer M; Riemekasten G
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101672. PubMed ID: 33745826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular players in angiogenesis during the course of systemic sclerosis.
    Cipriani P; Marrelli A; Liakouli V; Di Benedetto P; Giacomelli R
    Autoimmun Rev; 2011 Aug; 10(10):641-6. PubMed ID: 21549220
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of the regenerative effects of bone marrow/adipose-derived stem cells in the Asherman model following local or systemic administration.
    Monsef F; Artimani T; Alizadeh Z; Ramazani M; Solgi G; Yavangi M; Asl SS
    J Assist Reprod Genet; 2020 Aug; 37(8):1861-1868. PubMed ID: 32535814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis.
    Zhang H; Liang J; Tang X; Wang D; Feng X; Wang F; Hua B; Wang H; Sun L
    Arthritis Res Ther; 2017 Jul; 19(1):165. PubMed ID: 28724445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.